Showing results (1481-1490 of 1,591) with videos related to

Sort By:
Pageof 160
Archivos De Bronconeumologia|March 23, 2024
Multidisciplinary Consensus on the Management of Non-Invasive Respiratory Support in the COVID-19 PatientManel Luján, César Cinesi Gómez, Oscar Peñuelas, et al.
Chest|May 11, 2010
Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigatorsHervé Decousus, Victor F Tapson, Jean-François Bergmann, et al.
JAMA|September 15, 2025
Superficial Vein Thrombosis: A ReviewGregory Piazza, Darsiya Krishnathasan, Nada Hamade, et al.
Medical Mycology|October 17, 2025
Deep learning for the identification of Candida spp. directly from blood culture gram stains from candidemia patientsJuan Carlos Cuevas-Tello, Azael Monreal-de la Rosa, Juan Luis Quistian-Navarro, et al.
The European Respiratory Journal|August 13, 2021
Randomised controlled trial of a prognostic assessment and management pathway to reduce the length of hospital stay in normotensive patients with acute pulmonary embolismDavid Jiménez, Carmen Rodríguez, Francisco León, et al.
Multiple Sclerosis and Related Disorders|July 1, 2026
Discontinuation of disease-modifying therapies in patients with multiple sclerosis: A retrospective case-control studyG Cabañas Engenios, N Mena García, P Garay Albízuri, et al.
Journal of Neuroimmunology|August 9, 2024
Evaluating the complement C1q levels in serum and cerebrospinal fluid in multiple sclerosis patients: Could it serve as a valuable marker in clinical practice?Jordi Tortosa-Carreres, Laura Cubas-Núñez, Mónica Piqueras, et al.
Thrombosis Research|May 10, 2022
Sex Differences in PrEsentation, Risk Factors, Drug and Interventional Therapies, and OUtcomes of Elderly PatientS with Pulmonary Embolism: Rationale and design of the SERIOUS-PE studyBehnood Bikdeli, Gregory Piazza, David Jimenez, et al.
CNS Drugs|February 28, 2024
Real-World Retrospective Analysis of Alemtuzumab Outcomes in Relapsing-Remitting Multiple Sclerosis: The LEMCAM StudyLucienne Costa-Frossard França, Virginia Meca Lallana, Andrés Labiano-Fontcuberta, et al.
Genetics and Molecular Biology|February 24, 2018
Assessment of genetic integrity, splenic phagocytosis and cell death potential of (Z)-4-((1,5-dimethyl-3-oxo-2-phenyl-2,3dihydro-1H-pyrazol-4-yl) amino)-4-oxobut-2-enoic acid and its effect when combined with commercial chemotherapeuticsRodrigo Juliano Oliveira, Naiara da Cruz Leite Santos, João Renato Pesarini, et al.
Pageof 160